La syncope est une perte de connaissance subite et généralement momentanée qui peut avoir de graves effets indésirables. Les effets d'une syncope peuvent varier entre une chute et un accident fatal. La syncope nuit énormément à la qualité de vie liée à la santé du patient. Son fardeau sur le système de santé est considérable. Il n'y a pas de voie diagnostique claire pour en déterminer la cause. Ainsi, les patients peuvent être hospitalisés et subir des tests diagnostiques coûteux, souvent répétés et non concluants. Les moniteurs cardiaques implantables existent depuis plus d'une décennie pour contribuer au diagnostic précoce des cas inexpliqués de syncope. Cependant, même s'il s'agit d'une invention canadienne, leur utilisation est sous-optimale dans le système de santé canadien. La présente étude donne un aperçu de la syncope et de sa prise en charge, ainsi que des économies potentielles par diagnostic si le moniteur cardiaque implantable était utilisé systématiquement en Ontario.
Get full access to this article
View all access options for this article.
References
1.
BrignoleMAlboniPBendittDG et coll. Guidelines on management (diagnosis and treatment) of syncope. Europace2004; 6(6): 467–537.
2.
SoteriadesESEvansJCLarsonMGChenMHChenLBenjaminEJ. Incidence and prognosis of syncope. N Engl J Med2002; 347(12): 878–885.
3.
SilversteinMDSingerDEMulleyAGThibaultGEBarnettGO. Patients with syncope admitted to medical intensive care units. J Am Med Assoc1982; 248(10): 1185–1189.
4.
FarwellDJSulkeAN. Does the use of a syncope diagnostic protocol improve the investigation and management of syncope?Heart2004; 90(1): 52–58.
5.
FarwellDSulkeN. How do we diagnose syncope?J Cardiovasc Electrophysiol2002; 13(suppl): S9–S13.
6.
MiddlekauffHRStevensonWGStevensonLWSaxonLA. Syncope in advanced heart failure: High risk of sudden death regardless of origin of syncope. J Am Coll Cardiol1993; 21 (1): 110–116.
7.
BrignoleM. International study on syncope of uncertain aetiology: Pacemaker therapy for patients with asystolic neurally-mediated syncope: Rationale and study design. Europace2007; 9(1): 25–30.
8.
LeeSMOhHLKimJSYimHRShinDHLeeSH. Comparison of recurrence rate based on the frequency of preceding symptoms in patients with neurocardiogenic syncope or presyncope. Korean Circ J2011; 41(8): 434–439.
FitzpatrickAPCooperP. Diagnosis and management of patients with blackouts. Heart2006; 92(4): 559–568.
14.
AlshekhleeAShenWKMacKallJChelimskyTC. Incidence and mortality rates of syncope in the United States. Am J Med2009; 122(2): 181–188.
15.
LinzerMYangEHEstesNA et coll. Diagnosing syncope: Part 1: Value of history, physical examination, and electrocardiography. The clinical efficacy assessment project of the American College of Physicians. Ann Intern Med1997; 126(12): 989–996.
16.
BergfeldtL. Differential diagnosis of cardiogenic syncope and seizure disorders. Heart2003; 89 (3): 353.
17.
FarwellDJFreemantleNSulkeN. The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J2006; 27(3): 351–356.
18.
DisertoriMBrignoleMMenozziC et coll. Management of patients with syncope referred urgently to general hospitals. Europace2003; 5(3): 283–291.
SheldonRSMorilloCAKrahnAD et coll. Standardized approaches to the investigation of syncope: Canadian Cardiovascular Society position paper. Can J Cardiol2011; 27(2): 246–253.
21.
BrignoleMSuttonRMenozziC et coll. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J2006; 27(9): 1085–1092.
22.
EdhagOSwahnA. Prognosis of patients with complete heart block or arrhythmic syncope who were not treated with artificial pacemakers. A long-term follow-up study of 101 patients. Acta Med Scand1976; 200(6): 457–463.
23.
GassMApitzCSalehi-GilaniSZiemerGHofbeckM. Use of the implantable loop recorder in children and adolescents. Cardiol Young2006; 16(6): 572–578.
24.
ArmstrongVLLawsonJKamperAMNewtonJKennyRA. The use of an implantable loop recorder in the investigation of unexplained syncope in older people. Age Ageing2003; 32 (2): 185–188.
25.
KapoorWN. Diagnostic evaluation of syncope. Am J Med1991; 90(1): 91–106.
26.
LinzerMPritchettELPontinenMMcCarthyEDivineGW. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol1990; 66(2): 214–219.
27.
FitzpatrickAPLeeRJEpsteinLMLeshMDEisenbergSSheinmanMM. Effect of patient characteristics on the yield of prolonged baseline head-up tilt testing and the additional yield of drug provocation. Heart1996; 76 (5): 406.
28.
KrahnADKleinGJYeeRHochJSSkanesAC. Cost implications of testing strategy in patients with syncope: Randomized assessment of syncope trial. J Am Coll Cardiol2003; 42(3): 495–501.
29.
KrahnADKleinGJYeeRTakle-NewhouseTNorrisC. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation1999; 99(3): 406–410.
30.
KrahnADKleinGJYeeRMandaV. The high cost of syncope: Cost implications of a new insertable loop recorder in the investigation of recurrent syncope. Am Heart J1999; 137(5): 870–877.
31.
HillsM. The psychological and social impact of epilepsy. Neurol Asia2007; 12(suppl 1): 10–12.
32.
ZaidiACloughPCooperPScheepersBFitzpatrickAP. Misdiagnosis of epilepsy: Many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol2000; 36(1): 181–184.
33.
RoseMSKoshmanMLSprengSSheldonR. The relationship between health-related quality of life and frequency of spells in patients with syncope. J Clin Epidemiol2000; 53(12): 1209–1216.
34.
LinzerMPontinenMGoldDTDivineGWFelderABrooksWB. Impairment of physical and psychosocial function in recurrent syncope. J Clin Epidemiol1991; 44(10): 1037–1043.
35.
Medical Services Advisory Committee. Implantable loop recorder for unexplained recurrent syncope. MSAC application 1061. 〈www.ag.gov.au/cca〉; 2003. Consulté en décembre 2013.
36.
GuyattGCairnsJChurchillD et coll. Evidence-based medicine. A new approach to teaching the practice of medicine. J Am Med Assoc1992; 268(17): 2420–2425.
37.
MenonDStafinskiT. Technology assessment in Canada: 20 years strong?Value Health2009; 12(suppl 2): S14–S19.
38.
BleichrodtHQuigginJ. Life-cycle preferences over consumption and health: When is cost-effectiveness analysis equivalent to cost-benefit analysis?J Health Econ1999; 18(6): 681–708.
39.
MortimerDSegalL. Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights. Med Decis Making2007; 28(1): 66–89.
40.
MOHLTC. New Evidence-Based Changes to OHIP Services; 2011.
41.
ChengFYouJRampersaudR. Relationship between spinal magnetic resonance imaging findings and candidacy for spinal surgery. Can Fam Physician2012; 56 (11): 323.
42.
MorrisonA. Utilisation appropriée des techniques d'imagerie médicale de pointe: TDM, IRM et TEP/TDM [Analyses prospective, numéro 39]. Ottawa: Agence canadienne des médicaments et des technologies de la santé; 2013: 2013.
43.
Implant rates of ICM in various countries. Communications de Medtronic en 2013, données en dossier.
44.
DavisSWestbyMPitcherDPetkarS. Implantable loop recorders are cost-effective when used to investigate transient loss of consciousness which is either suspected to be arrhythmic or remains unexplained. Europace2012; 14(3): 402–409.
45.
KrahnADKleinGJYeeRHochJSSkanesAC. Cost implications of testing strategy in patients with syncope: Randomized assessment of syncope trial. J Am Coll Cardiol2003; 42(3): 495–501.
46.
CalkinsHByrneMel-AtassiRKalbfleischSLangbergJJMoradyF. The economic burden of unrecognized vasodepressor syncope. Am J Med1993; 95(5): 473–479.
47.
FarwellDJFreemantleNSulkeAN. Use of implantable loop recorders in the diagnosis and management of syncope. Eur Heart J2004; 25(14): 1257–1263.
48.
GiadaFGuliziaMFranceseM et coll. Recurrent unexplained palpitations study comparison of implantable loop recorder versus conventional diagnostic strategy. J Am Coll Cardiol2007; 49(19): 1951–1956.
49.
Agence canadienne des médicaments et des technologies de la santé. Tour d'horizon des technologies de la santé. Numéro 11; 2009.
50.
PronGIeraciLKaulbackK, Medical Advisory Secretariat, Health Quality Ontario. Internet-based device-assisted remote monitoring of cardiac implantable electronic devices: An evidence-based analysis. Ontario Health Technol Assess Ser2012; 12(1): 1–86.
